학술논문

Design of a Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Nipocalimab in Participants with Active Idiopathic Inflammatory Myopathies (SPIREA)
Document Type
Journal
Source
NEUROLOGY; APR 25 2023, 100 17, p2249 4p. Supplement: 2
Subject
Language
English
ISSN
1526632X